Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Aspirin 500 mg and hydrocodone bitartrate 5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and meprobamate 200 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and meprobamate 200 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and methocarbamol 400 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and methocarbamol 400 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
3 |
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
3 |
Atenolol 100 mg and chlortalidone 25 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Atenolol 100 mg and chlortalidone 25 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Atenolol 50 mg and chlortalidone 25 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Atenolol 50 mg and chlortalidone 25 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
atovaquon 62,5 mg + proguanilhydrochlorid 25 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
atovaquon 62,5 mg + proguanilhydrochlorid 25 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
atropin 0,025 mg + difenoxinhydrochlorid 1 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
atropin 0,025 mg + difenoxinhydrochlorid 1 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
3 |
Azatadine maleate 1 mg and pseudoephedrine sulfate 120 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Azatadine maleate 1 mg and pseudoephedrine sulfate 120 mg oral tablet |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
2 |
Azatadine maleate 1 mg and pseudoephedrine sulfate 120 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
3 |
Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
bisoprololfumarat 5 mg + hydrochlorthiazid 6,25 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
bisoprololfumarat 5 mg + hydrochlorthiazid 6,25 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Captopril 25 mg and hydrochlorothiazide 15 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Captopril 25 mg and hydrochlorothiazide 15 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Captopril 25 mg and hydrochlorothiazide 25 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Captopril 25 mg and hydrochlorothiazide 25 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Captopril 50 mg and hydrochlorothiazide 15 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Captopril 50 mg and hydrochlorothiazide 15 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
carbidopa 10 mg + levodopa 100 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
carbidopa 10 mg + levodopa 100 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
carbidopa 25 mg +levodopa 100 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
carbidopa 25 mg +levodopa 100 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
carbidopa25 mg + levodopa 250 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
carbidopa25 mg + levodopa 250 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Chlordiazepoxide hydrochloride 5 mg and clidinium bromide 2.5 mg oral capsule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Chlordiazepoxide hydrochloride 5 mg and clidinium bromide 2.5 mg oral capsule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Chlorothiazide 250 mg and methyldopa 250 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Chlorothiazide 250 mg and methyldopa 250 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Chlorothiazide 250 mg and reserpine 125 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Chlorothiazide 250 mg and reserpine 125 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
3 |
Product containing precisely hydralazine hydrochloride 100 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely hydralazine hydrochloride 100 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Methscopolamine 2.5 mg and pseudoephedrine hydrochloride 120 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Methscopolamine 2.5 mg and pseudoephedrine hydrochloride 120 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely nitrofurantoin macrocrystal 25 milligram and nitrofurantoin monohydrate 75 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely nitrofurantoin macrocrystal 25 milligram and nitrofurantoin monohydrate 75 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Amiloride hydrochloride 5 mg and hydrochlorothiazide 50 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Amiloride hydrochloride 5 mg and hydrochlorothiazide 50 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
amitriptylinhydrochlorid 12,5 mg + chlordiazepoxid 5 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
amitriptylinhydrochlorid 12,5 mg + chlordiazepoxid 5 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
amitriptylinhydrochlorid 10 mg + perphenazin 4 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
amitriptylinhydrochlorid 10 mg + perphenazin 4 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
amlodipinbesilat 2,5 mg + benazeprilhydrochlorid 10 mg kapsel |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
amlodipinbesilat 2,5 mg + benazeprilhydrochlorid 10 mg kapsel |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
amlodipinbesilat 5 mg + benazeprilhydrochlorid 10 mg kapsel |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
amlodipinbesilat 5 mg + benazeprilhydrochlorid 10 mg kapsel |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
amlodipinbesilat 5 mg + benazeprilhydrochlorid 20 mg kapsel |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
amlodipinbesilat 5 mg + benazeprilhydrochlorid 20 mg kapsel |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Amobarbital sodium 50 mg and secobarbital sodium 50 mg oral capsule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Amobarbital sodium 50 mg and secobarbital sodium 50 mg oral capsule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Olmesartan medoxomil 5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Olmesartan medoxomil 20 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Olmesartan medoxomil 40 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Nitisinone 2 mg oral capsule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely nitisinone 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Nitisinone 10 mg oral capsule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |